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EchoVIEW: Simultaneous Echocardiographic and
Physiologic Data Collection and Analysis
Software
11054-21
Wednesday, March 22,1995,10:30 a.m.-Noon
Ernest N. Morial Convention Center, La Louisiane A
Coronary Intervention: Device Selection
EchoVIEW's IP VI's include digital image readers, filtering routines, and
velocity profile extraction from pulsed, continuous, and color Doppler im-
ages. The package is currently used in research and clinical environments
to investigate diastolic function, left atrial appendage electrical/mechanical
function, and transvalvular catheter and Doppler gradient measurements.
The software package has proven to be an essential tool in studying com-
plex cardiovascular problems where simultaneous acquisition and analysis
of hemodynamic, electrophysiologic, and echocardiographic information are
important.
.~.
The EchoVIEW software package has been developed forthe acquisition and
analysis of simultaneous echocardiographic and physiologic data on both
Macintosh and PC platforms using LabVIEW (National Instruments, TX). This
graphical programming environment allows for data visualization and analy-
sis using a variety of modules, called virtual instruments (Vis). The data acqui-
sition VI allows for real-time visualization, digitization, and storage of eight
physiologic waveforms. Available inputs signals include fluid-filled or high-
fidelity micromanometer pressures, surface or atrial electrocardiograms, and
area or volume from acoustic quantification. Acquisition variables including
signal sources, amplification parameters, and sampling frequency are user
selectable. EchoVIEW's physiologic data processing Vis include automated
analysis of pressure waveforms (relaxation rate and dp/dt), transvalvular gra-
dients (instantaneous, peak, and mean pressures), and on-line reconstruc-
tion of pressure-volume loops. Doppler echocardiographic analysis Vis have
also been developed using a LabVIEW image processing (IP) library called
Concert Vi (Graftek Imaging, France).
Neil L. Greenberg, Pieter M. Vandervoort, William J. Stewart, James D. Thomas.
The Cleveland Clinic Foundation, Cleveland, Ohio
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1782-1 I Excimer Laser Coronary Angioplasty Versus Balloon
Angioplasty Used in Long Coronary Lesions: The
Longterm Results of the AMRO-Trial
Yolande EA Appelman, Jan J. Piek, Pim J. de Feyter, Jacques J. Koolen,
Sipke Strikwerda, James R. MargoliS, George K. David, Ken Redekop, Eline v.
Swljndregt, Patrick W. Serruys, Jan G.P. Tijssen, AMRO study group. The
Netherlands
From September 1991 until November 1993 we randomized 308 patients
with 325 long coronary lesions (> 10 mml to Excimer Laser Coronary Angio-
plasty (ELCA, n = 151) or Balloon Angioplasty (BA. n = 157). We report on the
longterm clinical and angiographic outcome of this trial. Procedural success
IPS) was defined as <50% residual stenosis at the end of the procedure.
Clinical endpoints were: death (D), myocardial infarction (MI), coronary by-
pass surgery (CABG) or repeat angioplasty (re-PTCA) of the randomized seg-
ment within 6 months follow-up. Angiographic endpoint was the net gain
ING) in minimal lumen diameter at six months follow-up relative to the pre-
procedural baseline determined by a computer-assisted automated edge de-
tection algorithm (CAAS II). Functional status (FS) at six months was graded
according to the Canadian Cardiovascular Society classification.
Results: Baseline patient characteristics were similar in both groups. ELCA
was followed bij BA in 98% of the treated lesions.
catheterization have been created to function in client server mode, providing
enhanced function and electronic data transfer. The network approach is per-
mitting expansion of the CDB into areas not previously included, specifically
electrophysiology, congestive heart failure and echocardiography. Ultimately
the financial data should be transferred over the network as well. This model,
consistent with contemporary computing, is already improving daily activity
and is expected to yet have a greater impact as the CDB, access tools and
local systems continually evolve and improve.
Cine Images in Cath Reports and Referral
Letters: A Complete Report Generated On-line in
Three Minutes
J. Larry Klein, Ryan M. Gill, Walter E. Mashman, Sara D. Gatlin. Emo'Y University,
Atlanta. Georgia
Wednesday, March 22,1995,9:00 a.m.-12:30 p.m.
Ernest N. Morial Convention Center, Hall B
Computerized Cardiology Laboratory
We have developed a multi-user 4th Dimension '" Macintosh '" database pro-
gram that logs procedures, keeps inventory and generates reports and re-
ferralletters. In addition to the text output. quick and simple methodologies
allow cine images to be captured in the cath lab, and automatically incorpo-
rated into the reports and referral letters. The images are digitized using stan-
dard Macintosh computers with a high quality gray scale digitizing board. The
software utilized is the public domain NIH Image software package. Macros
have been written to make the image acquisition and storage process very
simple requiring only a few keystrokes. If desired, quantitation of diameter
stenosis, vessel size, ejection fraction or valve area calculations can also be
easily performed. Included images are not limited to those acquired in the
cath lab. Scanned hemodynamic tracings, EKGs or any other image data can
be easily incorporated into the patient's database record off line. Images are
stored directly in the database and along with the report can be retrieved
at anytime. To conserve space and minimize network traffic, the images are
compressed approximately 10 to 1 using standard Macintosh Quicktime '"
routines. Alternatively, the images can be stored external to the data base
so that other applications can have access to them as well. The entire pro-
cess of generating a report, complete with images can be accomplished in
less than 3 minutes and requires minimal training. The reports and letters are
printed on standard laser printers and the image quality is excellent. As the
image to the left shows, a picture is truly worth a thousand words. This user
friendly system allows the clinicians to better care for their patients by giv-
ing them easy access not only to the written reports, but also to high quality
angiographic images.
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David P. Foley, Rein Melkert, Victor A. Umans, Peter P. de Jaegere, Patrick
W. Serruys Thoraxcentre, Erasmus University, Rotterdam, Netherlands
Left anterior descending (LAD) coronary artery location is reported to be
associated with increased propensity to restenosis after intervention. This
study, in 3736 patients, investigates whether this finding is equally applicable
to intervention with balloon angioplasty (BA, n = 3797 lesions), directional
atherectomy (DCA, n = 200 lesions), Palmaz-Schatz stent implantation (PS,
n ~ 229 lesions) and excimer laser angioplasty (ELCA, n = 116 lesions). Au-
tomated core laboratory quantitative analysis (OCA) was performed in mul-
tiple matched angiographic projections pre and post intervention and at 6
month follow up (overall QCA follow up 93%). Multiple linear regression
analysis was employed to determine whether LAD lesion location was asso-
ciated with greater propensity to luminal renarrowing, independently of le-
sion severity pre, procedural luminal increase and reference vessel diameter.
Because of the large variation in vessel size, lumen renarrowing was mea-
sured as relative luminal loss (minimal luminal diameter (MLD) post-follow
up/reference diameter pre) and angiographic outcome as relative lumen at
follow up (MLD at follow up/reference diameter pre). In multivariate analysis
applied to the entire patient population, LAD location was independently as-
sociated with greater relative loss and smaller lumen at follow up (p = 0.007).
However, application of the model to each patient group separately, revealed
analogous findings for the DCA (p = 0.003) and BA (p = 0.03) groups, but no
significant association between LAD location and late angiographic results
was evident in the PS (p = 0.18) or ELCA (p = 0.55) groups. Retrospective
exclusion of totally occluded lesions at baseline and/or at follow up from the
analysis did not appreciable alter these findings.
Conclusion: LAD lesions were independently associated with less
favourable late angiographic results after balloon angioplasty or directional
atherectomy, whereas late results after Palmaz-Schatz stent implantation or
excimer laser angioplasty did not vary with lesion location. In contrast with
previous reports, these findings suggest a differential influence of lesion lo-
cation on late interventional results, depending on the device used. Accord-
inglyfurther investigation will be required for clarification of this association.
(OR = 2.31, P < 0.05) failure. Although no ELCA effect was noted for late clin-
ical outcome (p = 0.56), a trend toward more ELCA-related events was seen
in TLR (RR = 1.43; P = 0.06). In conclusion: In lesion subsets suitable for
treatment with either device, ELCA-treated patients had: 1) lower Proc-S: 2)
more acute complications; and 3) a trend toward more frequent TLR than
RA-treated patients.
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Influence of Epicardial Lesion Location on Late
Luminal Renarrowing and Angiographic Outcome
After Successful Balloon Angioplasty, Directional
Atherectomy, Stent Implantation and Excimer Laser
Angioplasty
PSS DCA Balloon P
Lesion success (%) 117(95.9) 102 (944) 920 (95.3) 0.87
MLD post (mm) 2.87 ± 0.67 2.84 ± 0.77 2.20 ± 0.96 0.0001
In hospital death (%) 1 (0.9) 0(0.0) 410.5) 0.63
O-Wave MI (%) 2(1.8) 1(1.0) 15 (1.8) 0.85
CABG{%) 5(4.3) 3(2.9) 30(3.5) 0.84
6 months follow-up
PTCA(%) 31 (35) 30 (31) 247 (31) 0.74
CABG(%) 19 (22) 21 (22) 141 (19) 058
Recurrent angina (%) 34(37) 34(34) 340 (42) 0.25
Death (%) 918.5) 4 (39) 37 (4.3) 0.14
Both Palmaz-Schatz stents (PSS) and directional atherectomy (DCA) are re-
ported to be suitable for treating restenotic lesions and claim to decrease
subsequent restenosis. The purpose of this study was to compare in hos-
pital outcome and follow-up (FU) of these two technologies with balloon
angioplasty. Records of 1087 patients with restenosis that underwent elec-
tive (PSS) implantation (116 patients, 122 lesions). DCA (103 patients, 108
lesions), balloon angioplasty in 868 patients, 965 lesions) from January 1988
to March 1994 were reviewed. Mean follow-up was 1.22 ± 0.73 years.
Balloon Angioplasty, Palmaz-Schatz Stent, and
Directional Coronary Atherectomy for Restenotic
Lesions: Retrospective Comparison In a Single
Center
Ron Waksman, William S. Weintraub, Ziyad MB. Ghazzal, John S. Douglas Jr,
Yannan Shen, Spencer B. King III. Emory University School of Medicine, Atlanta, GA
29/611 014/0
2715/1 2/8/2
FS(I).IV)
ELCA(%)
178/217
63134t
70ttt183tt
21 ttt/13ttt
88ttt136ttt
12ttt/17tt
32ttt /2.0
48ttt /16t
87ttt I9ttt
40t /40t
07 ± 07
0.7 ± 07
NG± SD(mm)
RA(%)
518/682
63125
55/73
37/33
6.8/64
2719
13/0.5
65/22
95/2.7
31/29
0/1/4/10
0131218
D/MI/CABG/re-PTCAPS(%)
ELCA 49 65
BA 54 61
None of the comparisons were significantly different.
Conclusion: Excimer Laser Angioplasty compared to Balloon Angioplasty
in long coronary lesions yields similar results with respect to longterm clinical
and angiographic outcome.
None of the comparisons were significantly different.
Conclusion: Excimer Laser Angioplasty compared to Balloon Angioplasty
in functional and total coronary occlusion yields similar results with respect
to longterm clinical and angiographic outcome.
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1782-21 Longterm Outcome of Excimer Laser Angioplasty
Versus Balloon Angloplasty in Functional and Total
Coronary Occlusions
Yolande E.A. Appelman, Jacques J. Koolen, Pim J. de Feyter, Sipke Strikwerda,
George K. David, Ken Redekop, Eline v. SWijndregt, Patrick W. Serruys, Jan
G. Tijssen, Jan J. Piek, AMRO study group. The Netherlands
From September 1991 until November 1993 we randomized 103 patients
with functional and total coronary occlusions to Excimer Laser Coronary An-
gioplasty (ELCA, n = 49) or Balloon Angioplasty (BA, n = 54) as part of a
multi-center trial (AMRa) comparing ELCA versus BA in type B or C-Iesions.
We report on the longterm clinical and angiographic outcome of this sub-
group. Procedural success (PS) was defined as <50% residual stenosis at the
end of the procedure. Clinical endpoints were: death (D), myocardial infarc-
tion (MI), coronary bypass surgery (CABG) or repeat angioplasty (re-PTCA) of
the randomized segment within 6 months follow-up. Angiographic endpoint
was the net gain (NG) in minimal lumen diameter at six months follow-up
relative to the pre-procedural baseline determined by a computer-assisted
automated edge detection algorithm (CAAS II). Functional status (FS) at six
months was graded according to the Canadian Cardiovascular Society clas-
sification.
Results: Baseline patient characteristics were similar in both groups. ELCA
was followed by BA in all patients. Re-occlusion of the treated segment dur-
ing 6 months follow-up was 33% in the ELCA group versus 23% in the BA
group (not significant).
1782-31 Rotational Atherectomy vs. Excimer Laser
Angioplasty: A Multi-variable Analysis of Early and
Late Procedural Outcome
Gaston R. Dussaillant, Jeffrey J. Popma, Augusto D. Pichard, Lowell F. Satler,
Kenneth M. Kent, Ya Chien Chuang, Theresa A. Bucher, Benjamin Kleiber,
Anand Desai, Martin B. Leon Washington Hospital Center. Washington, DC
Rotational atherectomy (RA) and excimer laser angioplasty (ELCA) are com-
monly used in lesions unsuitable for balloon angioplasty, but few compara-
tive outcome studies have been performed using these devices in matched
subsets. To address this issue, we reviewed the clinical course of 696 pa-
tients undergoing RA or ELCA in lesions suitable for either technique. Vein
grafts, long (e::20 mm), heavily calcified, thrombus-containing lesions, and to-
tal occlusions were excluded. Angiographic «50% final stenosis), procedu-
ral (proc-S) «50% stenosis and no in-hospital complications [death, Q-wave
myocardial infarction QWMI or CABGI and clinical (Proc-S without rePTCA
<14 days) success, and late events (death, QWMI, target lesion revascu-
larization [TLR, CABG or repeat PTCA)) were recorded for 12 months af-
ter the procedure. Multivariate logistic regression analysis was performed
to evaluate the ELCA effect, accounting for disparities in clinical (unstable
angina, diabetes, multivessel disease) and angiographic (AHA/ACC classifi-
cation, restenosis, length, calcium, eccentricity, angulation, irregularity, and
pre-%DS) variables. ELCA remained an independent predictor for angio-
graphic (OR'" 3.72, P < 0.0051, procedural (OR = 2.96, P < 0.01), and clinical
t p < 005, ttp < 0.01, ttt p < 0.001
